Anglo American plc (BSM:ANGL)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions BWP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	424,651	500,849	408,670	604,689	583,477	440,669
Market Cap Growth	-19.39%	22.56%	-32.42%	3.64%	32.41%	16.81%
Enterprise Value	623,950	743,928	621,406	743,180	699,630	603,239
Last Close Price	446.87	443.46	378.81	197.67	166.51	139.89
PE Ratio	-	-	107.58	10.49	5.81	19.56
PS Ratio	1.20	1.32	0.99	1.35	1.20	1.61
PB Ratio	1.25	1.26	0.96	1.39	1.43	1.25
P/TBV Ratio	1.73	1.81	1.29	1.93	2.00	1.80
P/FCF Ratio	22.97	13.97	49.11	13.25	4.52	20.73
P/OCF Ratio	5.02	4.43	4.69	4.85	2.97	6.17
EV/Sales Ratio	1.77	1.96	1.51	1.66	1.43	2.20
EV/EBITDA Ratio	6.33	7.01	5.35	4.36	3.02	6.19
EV/EBIT Ratio	10.89	10.83	7.39	5.34	3.44	8.46
EV/FCF Ratio	33.76	20.75	74.67	16.28	5.42	28.37
Debt / Equity Ratio	0.66	0.67	0.56	0.42	0.37	0.41
Debt / EBITDA Ratio	2.32	2.37	1.96	1.08	0.65	1.47
Debt / FCF Ratio	12.22	7.38	28.33	4.02	1.18	6.87
Asset Turnover	0.42	0.42	0.46	0.53	0.65	0.43
Inventory Turnover	2.42	1.92	2.04	4.07	2.37	1.85
Quick Ratio	1.65	1.24	1.12	1.25	1.24	1.21
Current Ratio	2.72	2.13	1.85	1.90	1.79	1.93
Return on Equity (ROE)	-4.27%	-9.27%	4.10%	17.53%	34.64%	10.38%
Return on Assets (ROA)	4.16%	4.68%	5.84%	10.21%	16.84%	6.96%
Return on Capital (ROIC)	5.63%	6.37%	8.03%	14.18%	23.02%	9.34%
Return on Capital Employed (ROCE)	8.30%	8.90%	10.90%	19.10%	31.30%	12.40%
Earnings Yield	-13.39%	-8.54%	0.93%	9.53%	17.22%	5.11%
FCF Yield	4.35%	7.16%	2.04%	7.55%	22.11%	4.83%
Dividend Yield	2.22%	2.29%	3.86%	14.52%	23.13%	8.76%
Payout Ratio	-	-	552.65%	65.06%	35.59%	43.27%
Buyback Yield / Dilution	-5.75%	0.66%	0.49%	2.00%	0.16%	2.41%
Total Shareholder Return	-3.53%	2.94%	4.35%	16.52%	23.29%	11.17%

Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.